SCHEMBL6096285

SCHEMBL6096285

CC(=O)Nc1ccccc1Cc1ccc(O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.56
ALDH1A1 P00352 5/20 0.51
HPGD P15428 2/20 0.51
KEAP1 Q14145 1/20 0.51
BRD4 O60885 2/20 0.48
CYP2C19 P33261 2/20 0.46
POLB P06746 1/20 0.46
KDM4E B2RXH2 3/20 0.46
LMNA P02545 3/20 0.46
TSHR P16473 3/20 0.46
MAPT P10636 2/20 0.46
MEN1 O00255 1/20 0.46
CA12 O43570 1/20 0.46
NR1I2 O75469 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
MB P02144 1/20 0.46
CYP1A1 P04798 1/20 0.46
CA3 P07451 1/20 0.46
CYP3A4 P08684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7522410 0.88 L3MBTL1 (0.71) L3MBTL1ALDH1A1HPGDBRD4CYP2C19
SCHEMBL9167530 0.87 L3MBTL1 (0.56) L3MBTL1ALDH1A1HPGDBRD4LMNA
SCHEMBL6097904 0.86 L3MBTL1 (0.55) L3MBTL1ALDH1A1HPGDBRD4CYP2C19
SCHEMBL4610229 0.83 L3MBTL1 (0.52) L3MBTL1ALDH1A1KEAP1KDM4ELMNA
SCHEMBL28220176 0.83 ALDH1A1 (0.58) L3MBTL1ALDH1A1HPGDPOLBKDM4E
SCHEMBL19879879 0.83 HPGD (0.60) L3MBTL1ALDH1A1HPGDKEAP1CYP2C19
SCHEMBL7484877 0.83 TSHR (0.58) L3MBTL1ALDH1A1HPGDBRD4POLB
SCHEMBL6097282 0.81 CYP19A1 (0.51) L3MBTL1ALDH1A1HPGDPOLBMAPT
SCHEMBL17791491 0.80 TSHR (0.50) L3MBTL1ALDH1A1HPGDBRD4KDM4E
SCHEMBL6475322 0.78 ALDH1A1 (0.55) L3MBTL1ALDH1A1HPGDBRD4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115745-B2 Benzyl urea and thiourea derivatives WARNER LAMBERT COMPANY LLC (US) 2006-10-03 US disclosed
EP-1597233-A1 BENZYL UREA AND THIOUREA DERIVATIVES USEFUL AS ANDROGEN ANTAGONISTS Warner-Lambert Company LLC (US) 2005-11-23 EP disclosed
US-20050107427-A1 Benzyl urea and thiourea derivatives DU DANIEL Y (US) 2005-05-19 US disclosed
WO-2004072043-A1 BENZYL UREA AND THIOUREA DERIVATIVES USEFUL AS ANDROGEN ANTAGONISTS WARNER-LAMBERT COMPANY LLC (US) 2004-08-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107427-A1 Benzyl urea and thiourea derivatives BRDT, TAS2R8, FSHR L3MBTL1 4027/4885ALDH1A1 1968/4885HPGD 2063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.